000 01017 a2200301 4500
005 20250513145514.0
264 0 _c19980729
008 199807s 0 0 eng d
022 _a0003-9926
024 7 _a10.1001/archinte.158.13.1469-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDooley, D P
245 0 0 _aRevisiting doxycycline.
_h[electronic resource]
260 _bArchives of internal medicine
_cJul 1998
300 _a1469-70 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnti-Bacterial Agents
_xeconomics
650 0 4 _aAzithromycin
_xtherapeutic use
650 0 4 _aDoxycycline
_xeconomics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPatient Compliance
650 0 4 _aUnited States
650 0 4 _aUrethritis
_xdrug therapy
650 0 4 _aUterine Cervicitis
_xdrug therapy
773 0 _tArchives of internal medicine
_gvol. 158
_gno. 13
_gp. 1469-70
856 4 0 _uhttps://doi.org/10.1001/archinte.158.13.1469-a
_zAvailable from publisher's website
999 _c9631339
_d9631339